A splicing factor switch controls hematopoietic lineage specification of pluripotent stem cells
Yapu Li,Ding Wang,Hongtao Wang,Xin Huang,Yuqi Wen,BingRui Wang,Changlu Xu,Jie Gao,Jinhua Liu,Jingyuan Tong,Mengge Wang,Pei Su,Sirui Ren,Feng Ma,Hong‐Dong Li,Emery H Bresnick,Jiaxi Zhou,Lihong Shi
DOI: https://doi.org/10.15252/embr.202050535
IF: 9.071
2020-12-15
EMBO Reports
Abstract:<p>Alternative splicing (AS) leads to transcriptome diversity in eukaryotic cells and is one of the key regulators driving cellular differentiation. Although AS is of crucial importance for normal hematopoiesis and hematopoietic malignancies, its role in early hematopoietic development is still largely unknown. Here, by using high‐throughput transcriptomic analyses, we show that pervasive and dynamic AS takes place during hematopoietic development of human pluripotent stem cells (hPSCs). We identify a splicing factor switch that occurs during the differentiation of mesodermal cells to endothelial progenitor cells (EPCs). Perturbation of this switch selectively impairs the emergence of EPCs and hemogenic endothelial progenitor cells (HEPs). Mechanistically, an EPC‐induced alternative spliced isoform of NUMB dictates EPC specification by controlling NOTCH signaling. Furthermore, we demonstrate that the splicing factor SRSF2 regulates splicing of the EPC‐induced NUMB isoform, and the SRSF2‐NUMB‐NOTCH splicing axis regulates EPC generation. The identification of this splicing factor switch provides a new molecular mechanism to control cell fate and lineage specification.</p>
cell biology,biochemistry & molecular biology